High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
- PMID: 1348364
- PMCID: PMC48805
- DOI: 10.1073/pnas.89.7.3070
High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
Abstract
Exposure of human ovarian tumor cell lines to cisplatin led to development of cell lines that exhibited increasing degrees of drug resistance, which were closely correlated with increase of the levels of cellular glutathione. Cell lines were obtained that showed 30- to 1000-fold increases in resistance; these cells also had strikingly increased (13- to 50-fold) levels of glutathione as compared with the drug-sensitive cells of origin. These levels of resistance to cisplatin and the cellular glutathione levels are substantially greater than previously reported. Very high cisplatin resistance was associated with enhanced expression of mRNAs for gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase; immunoblots showed increase of gamma-glutamylcysteine synthetase but not of glutathione synthetase. Glutathione S-transferase activity was unaffected, as determined with chlorodinitrobenzene as a substrate. These studies suggest the potential value of examining regulation of glutathione synthesis as an indicator of clinical prognosis. The highly resistant cell lines are proving useful for studying the multiple mechanisms by which tumor cells acquire drug- and radiation-resistance.
Similar articles
-
Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.Cancer Res. 1995 Oct 1;55(19):4367-74. Cancer Res. 1995. PMID: 7671249
-
Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.Biochem Pharmacol. 1996 Jul 12;52(1):21-7. doi: 10.1016/0006-2952(96)00131-1. Biochem Pharmacol. 1996. PMID: 8678904
-
Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.Cancer Res. 1993 Nov 1;53(21):5225-32. Cancer Res. 1993. PMID: 8106143
-
Importance of glutathione and associated enzymes in drug response.Oncol Res. 1997;9(6-7):295-302. Oncol Res. 1997. PMID: 9406235 Review.
-
Regulation of cellular glutathione.Am J Physiol. 1989 Oct;257(4 Pt 1):L163-73. doi: 10.1152/ajplung.1989.257.4.L163. Am J Physiol. 1989. PMID: 2572174 Review.
Cited by
-
From Krebs to clinic: glutamine metabolism to cancer therapy.Nat Rev Cancer. 2016 Oct;16(10):619-34. doi: 10.1038/nrc.2016.71. Epub 2016 Jul 29. Nat Rev Cancer. 2016. PMID: 27492215 Free PMC article. Review.
-
RAD51AP1 Deficiency Reduces Tumor Growth by Targeting Stem Cell Self-Renewal.Cancer Res. 2020 Sep 15;80(18):3855-3866. doi: 10.1158/0008-5472.CAN-19-3713. Epub 2020 Jul 14. Cancer Res. 2020. PMID: 32665355 Free PMC article.
-
Expression of Drug-Resistant Factor Genes in Hepatocellular Carcinoma Patients Undergoing Chemotherapy with Platinum Complex by Arterial Infusion.Pharmaceutics. 2010 Sep 9;2(3):300-312. doi: 10.3390/pharmaceutics2030300. Pharmaceutics. 2010. PMID: 27721358 Free PMC article.
-
CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies.Mol Ther. 2020 Feb 5;28(2):548-560. doi: 10.1016/j.ymthe.2019.11.028. Epub 2019 Dec 6. Mol Ther. 2020. PMID: 31870622 Free PMC article.
-
Glutamine Metabolism in Brain Tumors.Cancers (Basel). 2019 Oct 24;11(11):1628. doi: 10.3390/cancers11111628. Cancers (Basel). 2019. PMID: 31652923 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials